Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search
PrintPrint
Simple search

Simple search

*
(*) mandatory field





Other search option(s)

70 Result(s)

Sort by

Caption : Accreditation =Accreditation
; Certification =Certification
;

    • BELGIUM
    • OOST-VLAANDEREN
    • GENT
    • Accreditation
Certification
    • Molecular diagnosis of optic atrophy type 1 (OPA1 gene)
    • Ghent University Hospital - UZGent
    • More information
    • FRANCE
    • ILE DE FRANCE
    • SAINT OUEN L'AUMONE
    • Accreditation
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • Laboratoire Cerba
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of autosomal dominant optic atrophy (OPA1 gene)
    • Medizinisch Genetisches Zentrum München
    • More information
    • NETHERLANDS
    • Noord-Holland
    • AMSTERDAM
    • Accreditation
    • Molecular diagnosis of Optic atrophy, type 1 (OPA1 gene)
    • AMC - Academisch Medisch Centum
    • More information
    • UNITED KINGDOM
    • South Glamorgan
    • CARDIFF
    • Accreditation
    • Molecular diagnosis of Autosomal Dominant Optic Atrophy, OPA1 type (by direct sequence analysis of 3q28-q29)
    • University Hospital of Wales NHS Trust
    • More information
    • UNITED KINGDOM
    • South Yorkshire
    • SHEFFIELD
    • Accreditation
    • Biochemical diagnosis of fatty acid oxidation defects and organic acidaemias (Analyte: Acyl carnitine by tandem MS)
    • Sheffield Children's NHS Foundation Trust
    • More information
    • UNITED KINGDOM
    • South Yorkshire
    • SHEFFIELD
    • Accreditation
    • Biochemical diagnosis of Organic acidaemias (Analyte: Qualitative organic acids)
    • Sheffield Children's NHS Foundation Trust
    • More information
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Accreditation
    • Biochemical diagnosis of fatty acid oxidation defects and organic acidaemias (Analyte: Acyl carnitine by tandem MS)
    • Royal Victoria Infirmary
    • More information
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Accreditation
    • Biochemical diagnosis of Organic acidaemias (Analyte: Organic acid specific quantitation, usually by stable isotope analysis)
    • Royal Victoria Infirmary
    • More information
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Accreditation
    • Biochemical diagnosis of Organic acidaemias (Analyte: Qualitative organic acids)
    • Royal Victoria Infirmary
    • More information
    • UNITED KINGDOM
    • West Yorkshire
    • LEEDS
    • Accreditation
    • Molecular diagnosis of Optic Atrophy 1 (partial coding region sequencing and dosage analysis, OPA1 gene)
    • St James's University Hospital
    • More information
    • BULGARIA
    •  South-West region
    • SOFIA
    • Certification
    • Biochemical diagnosis of organic aciduria using GCMS analysis
    • University hospital of Obstetrics and Gynecology
    • More information
    • ESTONIA
    • Tartu
    • TARTU
    • Certification
    • Molecular diagnosis of autosomal dominant optic atrophy (OPA1 gene) : genotyping by arrayed primer extension (APEX)
    • Asper Biotech Ltd.
    • More information
    • ISRAEL
    • ISRAEL
    • HAIFA
    • Certification
    • Molecular diagnosis of Costeff Optic Atrophy Syndrome (OPA3, Mutation analysis, Carrier screening)
    • Carmel Medical Center
    • More information
    • ISRAEL
    • ISRAEL
    • JERUSALEM
    • Certification
    • Molecular diagnosis of Costeff Optic Atrophy Syndrome (OPA3, Mutation analysis, Carrier screening)
    • Hadassah University Hospital
    • More information
    • ISRAEL
    • ISRAEL
    • PETAH TIKVA
    • Certification
    • Molecular diagnosis of Costeff Optic Atrophy syndrome (OPA3, Mutation analysis, Carrier screening)
    • Rabin Medical Center
    • More information
    • SPAIN
    • Galicia
    • SANTIAGO DE COMPOSTELA
    • Certification
    • molecular diagnosis of septooptic dysplasia. HESX1 gene
    • Fundación Pública Galega de Medicina Xenómica
    • More information
    • ISRAEL
    • ISRAEL
    • HAIFA
    • Certification
    • Molecular diagnosis of Costeff Optic Atrophy Syndrome (OPA3, Mutation analysis, Carrier screening)
    • The Bnai Zion Medical Center, Technion-Rappaport Faculty of Medicine
    • More information
    • ISRAEL
    • ISRAEL
    • RAMAT GAN
    • Certification
    • Molecular diagnosis of Costeff Optic Atrophy Syndrome (3MGA) (OPA3, Mutation analysis, Carrier screening, PGD)
    • Sheba Medical Center
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Certification
    • Molecular diagnosis of septooptic dysplasia. HESX1 gene.
    • GENETAQ
    • More information
    • DENMARK
    • Sjælland
    • GLOSTRUP
    • Prenatal and postnatal molecular diagnosis of type OPA1 optic atrophy (OPA1 gene: sequence analysis; carrier screening)
    • Kennedy Center
    • More information
    • ESTONIA
    • Tartu
    • TARTU
    • Diagnosis of organic acidurias : quantitative organic acid analysis (GC/MS)
    • United Laboratories - Tartu University Hospital
    • More information
    • FRANCE
    • ILE DE FRANCE
    • PARIS
    • Molecular diagnosis of combined pituitary hormon deficiency, syndromic or non-syndromic (HESX1, LHX3, LHX4, POU1F1, PROP1 and SOX2 genes)
    • CHU Hôpital d'Enfants Armand-Trousseau
    • More information
    • FRANCE
    • NORD-PAS DE CALAIS
    • LILLE
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • CHRU de Lille - Centre de biologie et pathologie
    • More information
    • GERMANY
    • Baden-Württemberg
    • FREIBURG
    • Molecular diagnosis of septooptic dysplasia (HESX1 gene)
    • Praxis für Humangenetik / Center for Human Genetics Freiburg
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Molecular diagnosis of septooptic dysplasia (HESX1 gene)
    • Universitätsklinikum Regensburg
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Molecular diagnosis of autosomal dominant optic atrophy (OPA1 gene)
    • Universitätsklinikum Regensburg
    • More information
    • GERMANY
    • Niedersachsen
    • OSNABRÜCK
    • Molecular diagnosis of septooptic dysplasia (HESX1 gene)
    • Zentrum für medizinische Genetik Osnabrück
    • More information
    • ITALY
    • PUGLIA
    • SAN GIOVANNI ROTONDO
    • Molecular diagnosis of septooptic dysplasia
    • IRCCS Ospedale Casa Sollievo della Sofferenza
    • More information
    • SPAIN
    • Andalucía
    • BARAKALDO
    • Molecular Diagnosis of Septooptic dysplasia. Sequentiation of the gene HESX1.
    • Hospital de Cruces - Osakidetza
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • Corporació Sanitària Clínic
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Biochemical diagnosis of 3-methylglutaconic aciduria, type 3
    • Corporació Sanitària Clínic
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • FRANCE
    • AQUITAINE
    • BORDEAUX
    • Biochemical diagnosis of 3-methylglutaconic aciduria types 1, 2, 3 and 4
    • CHU de Bordeaux - Hôpital Pellegrin
    • More information
    • FRANCE
    • BASSE NORMANDIE
    • CAEN
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • CHU Hôpital de la Côte de Nacre
    • More information
    • FRANCE
    • HAUTE NORMANDIE
    • ROUEN
    • Biochemical diagnosis of 3-methylglutaconic aciduria types 1, 2, 3 and 4
    • CHU Hôpital Charles Nicolle
    • More information
    • FRANCE
    • ILE DE FRANCE
    • PARIS
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • CHU de Paris - Hôpital Robert Debré
    • More information
    • FRANCE
    • ILE DE FRANCE
    • PARIS
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • Hopital Necker - Enfants Malades
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Molecular diagnosis of septooptic dysplasia (HESX1 gene)
    • CHRU de Montpellier - Hôpital Lapeyronie
    • More information
    • FRANCE
    • PAYS DE LOIRE
    • ANGERS
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • CHU d'Angers
    • More information
    • FRANCE
    • PAYS DE LOIRE
    • ANGERS
    • Molecular diagnosis of optic atrophy, dominant type (OPA1 gene)
    • CHU d'Angers
    • More information
    • FRANCE
    • PAYS DE LOIRE
    • ANGERS
    • Molecular diagnosis of methylglutaconicaciduria type III (OPA3 gene)
    • CHU d'Angers
    • More information
    • FRANCE
    • PAYS DE LOIRE
    • ANGERS
    • Molecular diagnosis of autosomal dominant optic atrophy and cataract (OPA3 gene)
    • CHU d'Angers
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Molecular diagnosis of septooptic dysplasia (HESX1 gene)
    • Hôpital de la Conception - AP-HM
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • NICE
    • FRANCE
    • RHONE-ALPES
    • BRON
    • Biochemical diagnosis of 3-methylglutaconic acidurias
    • Groupement Hospitalier Universitaire - Centre de Biologie et Pathologie Est
    • More information
    • FRANCE
    • RHONE-ALPES
    • GRENOBLE
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • CHU de Grenoble - Hôpital de la Tronche
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Biochemical diagnosis of 3-methylglutaconic aciduria (organic acids in urine)
    • Universitätsklinikum Heidelberg
    • More information
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Molecular diagnosis of autosomal dominant optic atrophy type Kjer (OPA1 gene)
    • Universitätsklinik Tübingen
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • LUDWIGSHAFEN
    • Molecular diagnosis of autosomal dominant optic atrophy (OPA1 gene)
    • Klinikum der Stadt Ludwigshafen gGmbH
    • More information
    • ITALY
    • CALABRIA
    • MANGONE
    • ITALY
    • EMILIA ROMAGNA
    • BOLOGNA
    • Molecular diagnosis of septooptic dysplasia (HESX1 gene)
    • Azienda Ospedaliera di Bologna - Policlinico S. Orsola-Malpighi
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • IRCCS Ospedale Pediatrico Bambino Gesù
    • More information
    • ITALY
    • LOMBARDIA
    • BRESCIA
    • Molecular diagnosis of septooptic dysplasia (HESX1 gene)
    • Università degli Studi di Brescia - Azienda Ospedaliera Spedali Civili
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Molecular diagnosis of multiple congenital pituitary deficiency
    • Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli e Regina Elena
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Biochemical diagnosis of 3-methylglutaconic aciduria, type 3
    • Ospedale dei Bambini ''Vittore Buzzi"
    • More information
    • ITALY
    • SARDEGNA
    • CAGLIARI
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • Ospedale Regionale per le Microcitemie - ASL 8
    • More information
    • ITALY
    • TOSCANA
    • FIRENZE
    • Biochemical diagnosis of 3-methylglutaconic aciduria
    • Azienda Ospedaliera Universitaria Anna Meyer
    • More information
    • ITALY
    • TOSCANA
    • SIENA
    • Molecular diagnosis of otptic atrophy
    • Policlinico "Le Scotte"
    • More information
    • ITALY
    • TOSCANA
    • SIENA
    • Molecular diagnosis of optic atrophy and cataract, autosomal dominant
    • Policlinico "Le Scotte"
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Biochemical diagnosis of 3-methylglutaconicaciduria
    • Instituto de Genética Médica Jacinto Magalhães
    • More information
    • SPAIN
    • Cataluña
    • ESPLUGUES DE LLOBREGAT
    • Biochemical diagnosis of optic atrophy.
    • Hospital Universitari Sant Joan de Déu
    • More information
    • SPAIN
    • Cataluña
    • ESPLUGUES DE LLOBREGAT
    • Biochemical diagnosis of 3-methylglutaconic aciduria, type 3.
    • Hospital Universitari Sant Joan de Déu
    • More information
    • SPAIN
    • Madrid
    • CANTOBLANCO
    • Biochemical and molecular diagnsosis of the 3-methylglutaconic aciduria. AUH, OPA3 genes
    • Universidad Autónoma de Madrid. Facultad de Ciencias
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of the septooptic dysplasia. HESX1 gene
    • Hospital Universitario La Paz
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of optic atrophy. OPA1 gen
    • Universidad Autónoma de Madrid. Facultad de Medicina
    • More information
    • SWEDEN
    • Stockholms läns landsting
    • STOCKHOLM
    • Molecular diagnosis of mitochondrial diseases (mtDNA/POLG/Twinkle)
    • Karolinska University Hospital
    • More information
    • UNITED KINGDOM
    • Oxfordshire
    • OXFORD
    • Molecular diagnosis of Mitochondrial diseases (POLG, PEO1, DGUOK, ANT1 & MPV17 genes)
    • Churchill Hospital, Oxford Radcliffe Hospitals NHS Trust
    • More information
    • UNITED KINGDOM
    • Strathclyde
    • GLASGOW
    • Biochemical diagnosis of fatty acid oxidation defects and organic acidaemias (Analyte: Acyl carnitine by tandem MS)
    • Royal Hospital for Sick Children - Yorkhill
    • More information
    • UNITED KINGDOM
    • Strathclyde
    • GLASGOW
    • Biochemical diagnosis of Organic acidaemias (Analyte: Qualitative organic acids)
    • Royal Hospital for Sick Children - Yorkhill
    • More information
Languages :